Investments

Co-Investment
Held / Exited
  • Vibrant_logo_1.png
    Co-Investment

    Vibrant Ingredients

    USA

    Consumer goods and services
    Consumer goods and services

    Founded in 1954, Vibrant Ingredients operates a multifunctional production facility and is involved in manufacturing of food protection ingredients, vegetable juice concentrates and derivatives used in a multitude of food applications from savory to beverages, sports nutrition and meats, and are marketed globally. The company offers a portfolio of healthy, natural, clean label solutions.

  • Logo Rodan and Fields
    Co-Investment

    Rodan & Fields

    USA

    Consumer goods and services
    Consumer goods and services

    Founded in 2002, Rodan & Fields is a North American skincare brand.

  • Logo ACA compliance group
    Co-Investment

    ACA COMPLIANCE GROUP

    USA

    Business services

    Exited

    Business services

    ACA Compliance Group is a market-leading regulatory compliance consultancy firm, providing recurring regulatory compliance, technology and performance attestation solutions primarily to traditional and alternative asset managers. ACA serves diversified clients, by both type of institutions and size of AUM.

  • Ramudden logo
    Co-Investment

    Ramudden

    Sweden

    Industrials
    Industrials

    AVS is #1 full-service highway traffic safety services provider in Germany. The Company develops, produces, sells and rents barrier walls as well as other traffic safety products. AVS has a nationwide presence with 14 locations across Germany and around 500 employees. Ramudden is #1 Swedish provider of traffic safety equipment for urban/rural areas in the Nordics. The Company is active in Sweden, Norway, Finland and Estonia. Ramudden employs ~300 FTE

The Ardian team brought a deep sector knowledge, which I think allowed them not only to do a terrific job in that due diligence period, but also meant they could work very efficiently within our deal time frame.

Doug Brody KKR Capital Market

Ardian and Arsenal both want our investments to benefit society and by working together in this case we’ve reduced the time it takes to set up a clinical trial by many months, which means new drugs come to market as quickly and safely as possible.

Steve McLean Partner of Arsenal Capital

During the due diligence phase, we identified Ardian as a future shareholder capable of making a significant contribution to Emera's development. As soon as the transaction closed, we were able to define and launch value-creating initiatives with Naxicap and Ardian, particularly in terms of group structuring, external growth, digital transformation and real estate strategy, in France but also in Spain and other European countries.

Eric Baugas CEO of EMERA